KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) FCF Margin (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of FCF Margin readings, the most recent being 142.78% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 1473.0% to 142.78% in Q4 2025 year-over-year; TTM through Dec 2025 was 105.04%, a 6327.0% increase, with the full-year FY2025 number at 105.04%, up 6327.0% from a year prior.
  • FCF Margin hit 142.78% in Q4 2025 for Ginkgo Bioworks Holdings, down from 81.38% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 13.75% in Q3 2021 to a low of 252.92% in Q1 2024.
  • Median FCF Margin over the past 5 years was 130.25% (2022), compared with a mean of 120.44%.
  • Biggest five-year swings in FCF Margin: surged 14495bps in 2022 and later plummeted -12239bps in 2023.
  • Ginkgo Bioworks Holdings' FCF Margin stood at 114.92% in 2021, then dropped by -15bps to 132.45% in 2022, then crashed by -33bps to 176.31% in 2023, then rose by 27bps to 128.05% in 2024, then decreased by -12bps to 142.78% in 2025.
  • The last three reported values for FCF Margin were 142.78% (Q4 2025), 81.38% (Q3 2025), and 81.23% (Q2 2025) per Business Quant data.